Organic electroluminescent materials and devices
US-2017352809-A1 · Dec 7, 2017 · US
US11930699B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11930699-B2 |
| Application number | US-202016983572-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 3, 2020 |
| Priority date | Aug 15, 2019 |
| Publication date | Mar 12, 2024 |
| Grant date | Mar 12, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are compounds comprising a ligand LA of Formula I
Opening claim text (preview).
What is claimed is: 1. A compound comprising a ligand L A of Formula I wherein: A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 1 and Z 2 are each independently C or N; K 3 and K 4 are each independently a direct bond, O, or S; X 1 , X 2 , and X 3 are each independently C or N, at least one of X 1 , X 2 , and X 3 is C; X is O or NR′; R A and R B each represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; each of R, R′, R A , and R B is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and two adjacent groups can be joined or fused to form a ring wherever chemically feasible, wherein the ligand L A is complexed to a metal M to form a chelate ring as indicated by the two dotted lines; the metal M can be coordinated to other ligands; and the ligand L A can be linked with other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. 2. The compound of claim 1 , wherein the compound has Formula II wherein: M 1 is Pd or Pt; rings C and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 3 and Z 4 are each independently C or N; K 1 , K 2 , K 3 , and K 4 are each independently selected from the group consisting of a direct bond, O, and S, wherein at least two of them are direct bonds; L 1 , L 2 , and L 3 are each independently selected from the group consisting of a single bond, absent a bond, O, S, CR″R′″, SiR″R′″, BR″, and NR″, at least one of L 1 and L 2 is not absent a bond; X 4 -X 6 are each independently C or N; R C and R D each independently represent zero, mono, or up to a maximum allowed substitution to its associated ring; each R″, R′″, R C , and R D is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; and two adjacent substituents can be joined or fused together to form a ring wherever chemically feasible. 3. The compound of claim 2 , wherein ring C is a 6-membered aromatic ring. 4. The compound of claim 2 , wherein L 1 is O, CRR′, or NR″. 5. The compound of claim 2 , wherein L 2 is a direct bond. 6. The compound of claim 2 , wherein L 2 is NR″. 7. The compound of claim 2 , wherein K 1 , K 2 , K 3 , and K 4 are each a direct bond. 8. The compound of claim 2 , wherein X 4 -X 5 are both N, and X 6 is C. 9. The compound of claim 2 , wherein L 3 is absent a bond. 10. The compound of claim 2 , wherein L 1 is absent a bond. 11. The compound of claim 2 , wherein the compound is selected from the group consisting of compounds having the formula of Pt(L A ′)(Ly) with the following structure: wherein L A ′ is selected from the group consisting of L A ′1-G to L A ′8-G whose structures are defined in LIST7A below, L A ″ is selected from the group consisting of L A ″9-G to L A ″16-G whose structures are defined in LIST7A below, L A ′″ is selected from the group consisting of L A ′″16-G whose structures are defined in LIST7A below, L A ″″ is selected from the group consisting of L A ″″17-G whose structures are defined in LIST7A below, and L A ′″″ is selected from the group consisting of L A ′″″18-G whose structures are defined in LIST7A below, and L A ″″″ is selected from the group consisting of L A ″″″19-G to L A ″″″21-G whose structures are defined in LIST7A below: LIST7A Ligand naming convention and structure L A ′1-G having the structure L A ′8-G having the structure L A ″15-G having the structure L A ′2-G having the structure L A ″9-G having the structure L A ″16-G having the structure L A ′3-G having the structure L A ″10-G having the structure L A ′′′16-G having the structure L A ′4-G having the structure L A ″11-G having the structure L A ′′″17-G having the structure
Organoboranes · CPC title
containing six or more rings · CPC title
containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene · CPC title
Organosilicon compounds, e.g. TIPS pentacene · CPC title
containing four rings, e.g. pyrene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.